Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: lactose monohydrate; macrogol 6000; colloidal anhydrous silica; microcrystalline cellulose; magnesium stearate; crospovidone; titanium dioxide; maize starch; purified talc; sunset yellow fcf aluminium lake; hypromellose; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: lactose monohydrate; colloidal anhydrous silica; microcrystalline cellulose; brilliant blue fcf aluminium lake; titanium dioxide; macrogol 6000; magnesium stearate; purified talc; hypromellose; maize starch; crospovidone - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: hypromellose; magnesium stearate; microcrystalline cellulose; purified talc; colloidal anhydrous silica; crospovidone; lactose monohydrate; quinoline yellow aluminium lake; titanium dioxide; macrogol 6000; maize starch - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 50 mg - tablet - excipient ingredients: microcrystalline cellulose; hypromellose; purified talc; crospovidone; maize starch; lactose monohydrate; macrogol 6000; colloidal anhydrous silica; sunset yellow fcf aluminium lake; titanium dioxide; magnesium stearate; indigo carmine aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 25 mg - tablet - excipient ingredients: lactose monohydrate; magnesium stearate; microcrystalline cellulose; quinoline yellow aluminium lake; macrogol 6000; purified talc; hypromellose; colloidal anhydrous silica; titanium dioxide; maize starch; crospovidone - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: colloidal anhydrous silica; hypromellose; lactose monohydrate; magnesium stearate; crospovidone; macrogol 6000; titanium dioxide; maize starch; microcrystalline cellulose; purified talc; brilliant blue fcf aluminium lake - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - enalapril maleate, quantity: 20 mg - tablet - excipient ingredients: maleic acid; hypromellose; sodium stearylfumarate; lactose monohydrate; croscarmellose sodium - hypertension ,enalapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. ,congestive heart failure ,enalapril is indicated for the treatment of all degrees of symptomatic heart failure. in such patients, it is recommended that enalapril be administered together with a diuretic. ,left ventricular dysfunction ,all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35 percent, irrespective of the presence or severity of obvious symptoms of heart failure.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - enalapril maleate, quantity: 10 mg - tablet - excipient ingredients: maleic acid; croscarmellose sodium; lactose monohydrate; sodium stearylfumarate; hypromellose - hypertension ,enalapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. ,congestive heart failure ,enalapril is indicated for the treatment of all degrees of symptomatic heart failure. in such patients, it is recommended that enalapril be administered together with a diuretic. ,left ventricular dysfunction ,all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35 percent, irrespective of the presence or severity of obvious symptoms of heart failure.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - enalapril maleate, quantity: 5 mg - tablet - excipient ingredients: croscarmellose sodium; sodium stearylfumarate; lactose monohydrate; maleic acid; hypromellose - hypertension ,enalapril is indicated in the treatment of all grades of essential hypertension and renovascular hypertension. ,congestive heart failure ,enalapril is indicated for the treatment of all degrees of symptomatic heart failure. in such patients, it is recommended that enalapril be administered together with a diuretic. ,left ventricular dysfunction ,all degrees of left ventricular dysfunction where the left ventricular ejection fraction is less than 35 percent, irrespective of the presence or severity of obvious symptoms of heart failure.

Australien - engelsk - Department of Health (Therapeutic Goods Administration)

ipca pharma (australia) pty ltd - donepezil hydrochloride, quantity: 5 mg - tablet, film coated - excipient ingredients: hyprolose; macrogol 6000; microcrystalline cellulose; titanium dioxide; lactose monohydrate; hypromellose; sodium stearylfumarate; purified talc; maize starch - donepezil is indicated for the treatment of mild, moderate and severe alzheimer's disease.